May 22,2020

Ampersand today announces Innovate UK grant win to develop digital therapy solutions for people with Rheumatoid Arthritis

The UK government today announced that 800 innovative businesses and start-ups – including Ampersand Health – are set to benefit from a £40 million investment to drive forward new technological advances, particularly as a response to the Covid19 outbreak. The Innovate UK funding will allow the company and its partners – including the National Rheumatoid Arthritis Society – to invest in and evidence similar new behavioural medicines for people living with inflammatory arthritis.

FUNDING GRANT
View Analyst & Ambassador Comments
Go to original news
Jun 03,2020

Swedish company is awarded prestigious grant

In strong competition GAEU’s client Vicore Pharma Holding AB (publ) was awarded £ 1.5 million by the British charity LifeArc for a COVID-19 Phase II study with the drug candidate VP01. The study, named ATTRACT (Angiotensin II Type Two Receptor Agonist COVID-19 Trial), is targeting hospitalized patients treated with basic respiratory care, but not yet on mechanical ventilation. In close cooperation between the GAEU’s and Vicore’s team, the winning application was written in record time.

FUNDING GRANT
View Analyst & Ambassador Comments
Go to original news
Dec 01,2020

Xploro Raises £150K from GC Angles

In December 2020, Xploro secured £150,000 from GC Angels to expand its design and development teams in Manchester, aiming to grow its headcount from 2 to 16 by the end of 2021.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Dec 30,2020

BehaVR Raises $7.2M in Equity Funding

BehaVR registered $7.2 million fundings according to the SEC form.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Jan 14,2021

KidsX, the Largest Pediatric-Focused Digital Health Accelerator in the World, Selects 13 Startups for Inaugural Cohort

KidsX, an international consortium of pediatric hospitals focused on improving digital health innovation through collaboration, has selected 13 startup companies, including Xploro and Limbix, to be part of its inaugural accelerator cohort. Led by the Innovation Studio at Children's Hospital Los Angeles (CHLA), KidsX facilitates relationships between leading children’s hospitals and entrepreneurial innovators to build, test and deploy software solutions to make pediatric care exceptionally effective, safe, efficient and convenient for children and families.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Feb 12,2021

Blue Note Therapeutics Raises $15.5M

The document is a Form D filing submitted to the U.S. Securities and Exchange Commission (SEC) by Blue Note Therapeutics, a clinical stage digital therapeutics company that develops prescription digital therapeutics for neurological and psychiatric disorders. The purpose of the filing is to disclose that Blue Note Therapeutics has raised $12,999,998 in equity financing. The funds will be used to support the company's growth and expansion efforts.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Apr 14,2021

2Morrow Raises $1.5M to Increase Access to Evidence-Based Digital Health

2Morrow, Inc., a leader in offering evidence-based, digital health platforms, announces a $1.5M investment led by Seattle area life science investor WRF Capital. The funding will be used to support growth of 2Morrow’s current platform and expansion into medical grade, digital therapeutic solutions for chronic conditions.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
May 14,2021

Xploro targets US with new £1.5m funding round

Xploro, a platform that uses augmented reality, gameplay and artificial intelligence to deliver health information to young patients, is aiming to raise over £1.5m to expand in the US following a funding round led by GC Angels last year.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
May 25,2021

Noom Announces $540 Million in Growth Funding to Further Accelerate Expansion of its Digital Health Platform

Noom, the leading digital health platform focused on behavior change, today announced its approximately $540 million Series F funding led by Silver Lake. Other new investors participating in the round include Oak HC/FT, Temasek, and Novo Holdings. Existing investors Sequoia Capital, RRE, and Samsung Ventures also participated. Building on the strong foundation of its weight management business, Noom will use the newly-raised capital to expand its highly-adaptable behavior change platform to address a broad range of conditions with meaningful opportunity to further generate positive change across the lives and health of its customers, including stress and anxiety, diabetes, hypertension, and sleep. The funds will also enable Noom to reach more people in more places—from new geographies to employee benefits programs. A portion of the new capital is also being used for share repurchases as part of the company’s broader capital allocation framework.

FUNDING SERIES F
View Analyst & Ambassador Comments
Go to original news
Jun 23,2021

NuvoAir Raises $12M in Series A Funding

NuvoAir raised $12 million in Series A funding. The round was led by AlbionVC, with participation from KAYA (formerly Enern), Amino Collective and existing shareholders Spiltan, Industrifonden and Novartis Pharma AG.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING